Cargando…

Apolipoprotein D as a Potential Biomarker in Neuropsychiatric Disorders

Neuropsychiatric disorders (NDs) are a diverse group of pathologies, including schizophrenia or bipolar disorders, that directly affect the mental and physical health of those who suffer from them, with an incidence that is increasing worldwide. Most NDs result from a complex interaction of multiple...

Descripción completa

Detalles Bibliográficos
Autores principales:	del Valle, Eva, Rubio-Sardón, Nuria, Menéndez-Pérez, Carlota, Martínez-Pinilla, Eva, Navarro, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650001/ https://www.ncbi.nlm.nih.gov/pubmed/37958618 http://dx.doi.org/10.3390/ijms242115631

Ejemplares similares

Neuroprotective Effect of Apolipoprotein D in Cuprizone-Induced Cell Line Models: A Potential Therapeutic Approach for Multiple Sclerosis and Demyelinating Diseases
por: Martínez-Pinilla, Eva, et al.
Publicado: (2021)

Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions
por: Navarro, Ana, et al.
Publicado: (2018)

Lifelong Expression of Apolipoprotein D in the Human Brainstem: Correlation with Reduced Age-Related Neurodegeneration
por: Navarro, Ana, et al.
Publicado: (2013)

Cuprizone-Induced Neurotoxicity in Human Neural Cell Lines Is Mediated by a Reversible Mitochondrial Dysfunction: Relevance for Demyelination Models
por: Martínez-Pinilla, Eva, et al.
Publicado: (2021)

Regional and Gender Study of Neuronal Density in Brain during Aging and in Alzheimer's Disease
por: Martínez-Pinilla, Eva, et al.
Publicado: (2016)

Behavioral Biomarkers of Schizophrenia in High Drinker Rats: A Potential Endophenotype of Compulsive Neuropsychiatric Disorders
por: Navarro, Silvia V., et al.
Publicado: (2017)

Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders
por: Potes, Yaiza, et al.
Publicado: (2023)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Autoantibodies in Neuropsychiatric Disorders
por: Hoffmann, Carolin, et al.
Publicado: (2016)

The Impact of Vitamin D on Neuropsychiatric Disorders
por: Wassif, Ghada A, et al.
Publicado: (2023)

Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders
por: Sethi, Sumit, et al.
Publicado: (2015)

The Epigenetic Cytocrin Pathway to the Nucleus. Epigenetic Factors, Epigenetic Mediators, and Epigenetic Traits. A Biochemist Perspective
por: Navarro, Gemma, et al.
Publicado: (2017)

Therapeutic Potential of the Microbiome in the Treatment of Neuropsychiatric Disorders
por: Evrensel, Alper, et al.
Publicado: (2019)

Identification of Biomarkers in Neuropsychiatric Disorders Based on Systems Biology and Epigenetics
por: Peedicayil, Jacob
Publicado: (2019)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders
por: Rodríguez-Landa, Juan Francisco, et al.
Publicado: (2023)

Patient Satisfaction and Treatments Offered to Swedish Patients with Suspected Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections
por: Hesselmark, Eva, et al.
Publicado: (2019)

Circadian Influences on the Habenula and Their Potential Contribution to Neuropsychiatric Disorders
por: Young, Callum J., et al.
Publicado: (2022)

Increase in placental apolipoprotein D as an adaptation to human gestational diabetes
por: Navarro, A., et al.
Publicado: (2010)

Reelin and Neuropsychiatric Disorders
por: Ishii, Kazuhiro, et al.
Publicado: (2016)

The genetics of neuropsychiatric disorders
por: Bray, Nicholas J., et al.
Publicado: (2018)

Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
por: Behbodikhah, Jennifer, et al.
Publicado: (2021)

Gut microbiome in neuropsychiatric disorders
por: MEJÍA-GRANADOS, Diana Marcela, et al.
Publicado: (2022)

Albumin and Associated Biomarkers in Severe Neuropsychiatric Disorders: Acute-Phase Schizophrenia and Bipolar Disorder
por: Xu, Haiting, et al.
Publicado: (2023)

Redox Modulations, Antioxidants, and Neuropsychiatric Disorders
por: Fraunberger, Erik A., et al.
Publicado: (2016)

Neuropsychiatric Disorders in Chronic Kidney Disease
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2019)

Rational design of cancer gene panels with OncoPaD
por: Rubio-Perez, Carlota, et al.
Publicado: (2016)

Changes in Histaminergic System in Neuropsychiatric Disorders and the Potential Treatment Consequences
por: Shan, Ling, et al.
Publicado: (2022)

Antioxidant Supplements versus Health Benefits of Brief/Intermittent Exposure to Potentially Toxic Physical or Chemical Agents
por: Franco, Rafael, et al.
Publicado: (2021)

Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status
por: Xing, Yi, et al.
Publicado: (2015)

Cognitive and Neuropsychiatric Impairment in Dystonia
por: Bailey, Grace A., et al.
Publicado: (2022)

Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
por: Watanabe, Yumi, et al.
Publicado: (2020)

Identification of Apolipoprotein E as a Potential Diagnostic Biomarker of Nasopharyngeal Carcinoma
por: Xue, Ying, et al.
Publicado: (2020)

Exosomes as Emerging Biomarker Tools in Neurodegenerative and Neuropsychiatric Disorders—A Proteomics Perspective
por: Mathew, Boby, et al.
Publicado: (2021)

A Comprehensive Evaluation of Cross-Omics Blood-Based Biomarkers for Neuropsychiatric Disorders
por: Song, Weichen, et al.
Publicado: (2021)

Fatty acids and neuropsychiatric disorders
por: Puri, Basant K
Publicado: (2008)

Maintenance Pharmacotherapies for Neuropsychiatric Disorders
por: Richards, Stephanie
Publicado: (2013)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

Epigenetic Regulations in Neuropsychiatric Disorders
por: Kuehner, Janise N., et al.
Publicado: (2019)

Neuropsychiatric disorders and COVID-19
por: Charlton, Elizabeth, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jm6k5f6307mmbnq22h50o12338